Tremfya (guselkumab) is a prescription drug that’s used to treat certain autoimmune conditions, including plaque psoriasis. Tremfya can cause side effects that range from mild to serious.

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...

Taltz (ixekizumab) is a prescription drug that treats certain autoimmune conditions, including plaque psoriasis. You will receive Taltz as an injection under your skin. It can interact with ...

Researchers at the University of Copenhagen have developed a patch for easier and more effective treatment of psoriasis. The ...

And beyond the physical symptoms, plaque psoriasis also frequently has negative effects on mental health and alters the lifestyle of those living with it. Here are five ways that this skin condition ...

J&J’s Janssen unit and partner Protagonist Therapeutics hope to show that the peptide drug can be an alternative to injectable biologics for plaque psoriasis, including drugs working on IL-23 ...

Statistically significant improvements were also achieved across all major secondary endpoints, including: 52.9% achieved a Psoriasis Area Severity Index (PASI) 90 response compared to 6.2% of ...

Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...

"The approval of Sotyktu represents an exciting day for patients suffering from moderate-to-severe plaque psoriasis who are not satisfied with topical and conventional treatments," said Samit ...

Although CBD is widely considered safe, there still aren’t many studies specifically on CBD and plaque psoriasis ... have a fear of other invasive treatments, or are looking for a natural ...

Johnson & Johnson recently rolled out a TV ad that takes aim at a major disparity in dermatology: the fact that people of ...

moderate plaque psoriasis (PsO) with special site involvement who had failed topical treatment. Data from the Phase 3b SPECTREM study to measure skin clearance and other treatment outcomes in low ...